Download Docs
Export
Print

BIOCRYST

88073891 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Aug. 10, 2018
Serial No. 88073891
Registered April 2, 2019
Registration No. 5,713,814
Class Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; 006; 018; 044; 046; 051; 052
BIOCRYST
Status Registered. The registration date is used to determine when post-registration maintenance documents are due.
Last Updated: 3 years, 3 months ago
Filing Date # Docket Text
to view the full docket.